Alerts will be sent to your verified email
Verify EmailUNICHEMLAB
Unichem Lab
|
Concord Biotech
|
Dishman Carbogen Amc
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
41.0 . | n/a | n/a |
Number of ANDA's Approved By USFDA
|
27.0 . | n/a | n/a |
R&D as a % of Total Sales
|
0.94 % | 2.26 % | 2.89 % |
Financials
|
|||
5 yr Average ROE
|
-1.8 % | 20.02 % | 0.72 % |
5yr average Equity Multiplier
|
1.25 | 1.26 | 1.49 |
5yr Average Asset Turnover Ratio
|
0.39 | 0.52 | 0.25 |
5yr Avg Net Profit Margin
|
-3.43 % | 30.81 % | 1.79 % |
Price to Book
|
1.54 | 10.58 | 0.48 |
P/E
|
0.0 | 52.42 | 0.0 |
5yr Avg Cash Conversion Cycle
|
134.58 Days | 37.41 Days | 42.6 Days |
Inventory Days
|
136.89 Days | 80.96 Days | 101.13 Days |
Days Receivable
|
147.31 Days | 111.87 Days | 80.42 Days |
Days Payable
|
232.31 Days | 173.13 Days | 166.8 Days |
5yr Average Interest Coverage Ratio
|
-1.13 | 137.55 | 2.31 |
5yr Avg ROCE
|
-1.02 % | 25.59 % | 2.38 % |
5yr Avg Operating Profit Margin
|
5.06 % | 46.79 % | 20.95 % |
5 yr average Debt to Equity
|
0.09 | 0.04 | 0.23 |
5yr CAGR Net Profit
|
53.41 % | 12.77 % | n/a |
5yr Average Return on Assets
|
-1.39 % | 15.93 % | 0.54 % |
Shareholdings
|
|||
Promoter Holding
|
70.22 % | 44.08 % | 59.32 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
19.29 % | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
1.59 % | -0.43 % | -6.64 % |
Unichem Lab
|
Concord Biotech
|
Dishman Carbogen Amc
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|